Challenges in translating clinical guidelines into real-life practice for management of hepatocellular carcinoma in Taiwan

by San-Chi Chen
Published 2023-04-01

Pulse corticosteroid therapy in the treatment of steroid-refractory immune checkpoint inhibitor-related pneumonitis: Case report and review

by Kuan-Chang Lai, Yi-Han Hsiao, San-Chi Chen
Published 2022-08-01

890 Nivolumab plus ipilimumab in anti-PD(L)-1 naïve and experienced HCC patients — single institute experience in Taiwan

by San-Chi Chen, Ming-Huang Chen, Nai-Jung Chiang
Published 2023-11-01

Sick sinus syndrome associated with anti-programmed cell death-1

by Chien-Yi Hsu, Yu-Wen Su, San-Chi Chen
Published 2018-07-01

Emerging roles of epithelial-mesenchymal transition in hematological malignancies

by San-Chi Chen, Tsai-Tsen Liao, Muh-Hwa Yang
Published 2018-04-01

Perivascular Epithelioid Cell Tumors (PEComas) Refractory to mTOR Inhibitors

by San-Chi Chen, Chian-Wen Yang, Chueh-Chuan Yen, Cheng-Huai Tseng, Ta-Chung Chao
Published 2014-09-01

Upregulation of USP22 and ABCC1 during Sorafenib Treatment of Hepatocellular Carcinoma Contribute to Development of Resistance

by Yung-Sheng Chang, Chien-Wei Su, San-Chi Chen, Yen-Ying Chen, Yuh-Jin Liang, Jaw-Ching Wu
Published 2022-02-01

Anti-PD-1 combined sorafenib versus anti-PD-1 alone in the treatment of advanced hepatocellular cell carcinoma: a propensity score-matching study

by San-Chi Chen, Yi-Hsiang Huang, Ming-Huang Chen, Yi-Ping Hung, Rheun-Chuan Lee, Yu-Yun Shao, Yee Chao
Published 2022-01-01

Correction: Secondary Solid Organ Neoplasm in Patients with Acute Lymphoblastic Leukemia: A Nationwide Population-Based Study in Taiwan.

by Chung-Jen Teng, Leh-Kiong Huon, Yu-Wen Hu, Chiu-Mei Yeh, Sheng-Hsuan Chien, San-Chi Chen, Chia-Jen Liu
Published 2016-01-01

Secondary Solid Organ Neoplasm in Patients with Acute Lymphoblastic Leukemia: A Nationwide Population-Based Study in Taiwan.

by Chung-Jen Teng, Leh-Kiong Huon, Yu-Wen Hu, Chiu-Mei Yeh, Sheng-Hsuan Chien, San-Chi Chen, Chia-Jen Liu
Published 2016-01-01

Determinants of Survival and Post-Progression Outcomes by Sorafenib–Regorafenib Sequencing for Unresectable Hepatocellular Carcinoma

by I-Cheng Lee, Yee Chao, Pei-Chang Lee, San-Chi Chen, Chen-Ta Chi, Chi-Jung Wu, Kuo-Cheng Wu, Ming-Chih Hou, Yi-Hsiang Huang
Published 2022-04-01

Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma

by Pei-Chang Lee, Yee Chao, Ming-Huang Chen, Keng-Hsin Lan, Chieh-Ju Lee, I-Cheng Lee, San-Chi Chen, Ming-Chih Hou, Yi-Hsiang Huang
Published 2020-01-01

Rheumatoid arthritis and the risk of bipolar disorder: a nationwide population-based study.

by Chih-Chao Hsu, San-Chi Chen, Chia-Jen Liu, Ti Lu, Cheng-Che Shen, Yu-Wen Hu, Chiu-Mei Yeh, Pan-Ming Chen, Tzeng-Ji Chen, Li-Yu Hu
Published 2014-01-01

Risk of cancer in patients with iron deficiency anemia: a nationwide population-based study.

by Ning Hung, Cheng-Che Shen, Yu-Wen Hu, Li-Yu Hu, Chiu-Mei Yeh, Chung-Jen Teng, Ai-Seon Kuan, San-Chi Chen, Tzeng-Ji Chen, Chia-Jen Liu
Published 2015-01-01

Durable objective response to sorafenib and role of sequential treatment in unresectable hepatocellular carcinoma

by Kuo-Wei Huang, Pei-Chang Lee, Yee Chao, Chien-Wei Su, I-Cheng Lee, Keng-Hsin Lan, Chi-Jen Chu, Yi-Ping Hung, San-Chi Chen, Ming-Chih Hou, Yi-Hsiang Huang
Published 2022-05-01

Secondary primary malignancy risk among patients with esophageal cancer in Taiwan: a nationwide population-based study.

by San-Chi Chen, Chung-Jen Teng, Yu-Wen Hu, Chiu-Mei Yeh, Man-Hsin Hung, Li-Yu Hu, Fan-Chen Ku, Cheng-Hwai Tzeng, Tzeon-Jye Chiou, Tzeng-Ji Chen, Chia-Jen Liu
Published 2015-01-01

Risk of Second Non-Breast Primary Cancer in Male and Female Breast Cancer Patients: A Population-Based Cohort Study.

by Man-Hsin Hung, Chia-Jen Liu, Chung-Jen Teng, Yu-Wen Hu, Chiu-Mei Yeh, San-Chi Chen, Sheng-Hsuan Chien, Yi-Ping Hung, Cheng-Che Shen, Tzeng-Ji Chen, Cheng-Hwai Tzeng, Chun-Yu Liu
Published 2016-01-01

Outcomes of post-immunotherapy durable responders of advanced hepatocellular carcinoma - with emphasis on locoregional therapy for oligoprogression

by Tsung-Hao Liu, San-Chi Chen, Kun-Ming Rau, Li-Chun Lu, Po-Ting Lin, Yung-Yeh Su, Wei Teng, Shiue-Wei Lai, Ren-Hua Yeh, Tsui-Mai Kao, Pei-Chang Lee, Chi-Jung Wu, Chien-Hung Chen, Chih-Hung Hsu, Shi-Ming Lin, Yi-Hsiang Huang, Li-Tzong Chen, Ann-Lii Cheng, Ying-Chun Shen
Published 2024-02-01

Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroent...

by Yu-Yun Shao, Shen-Yung Wang, Shi-Ming Lin, Kuan-Yang Chen, Jeng-Hwei Tseng, Ming-Chih Ho, Rheun-Chuan Lee, Po-Chin Liang, Li-Ying Liao, Kai-Wen Huang, Jui-Ting Hu, Ja-Der Liang, Shen-Yung Wang, Kwong-Ming Kee, Chih-Lin Lin, Shi-Ming Lin, Chung-Kwe Wang, Sheng-Nan Lu, Jing-Houng Wang, Wei-Chen Lee, Chien-Hung Chen, Chun-Jen Liu, Yi-Hsiang Huang, Chia-Chi Wang, Tsang-En Wang, Po-Heng Chuang, Chia-Yen Dai, Chiun Hsu, Yu-Yun Shao, San-Chi Chen, Chia-Hsun Hsieh
Published 2021-04-01